Minimally Invasive Healthcare (00853) issued a profit warning and is expected to make a net loss in the medium term

Zhitong Finance App News, Minimally Invasive Healthcare (00853) announced that the Group's performance for the six months ended June 30, 2026 is expected as follows: the Group's continuing business revenue achieved a year-on-year increase of about 12% to 14%; in particular, the overseas business continued to contribute strong growth of about 140%; the Group's operating profitability improved steadily, the gross margin of the continuing operation business increased by about 3 to 4 percentage points year on year, and continued to promote refined operation and cost control. During the period, the net operating profit from continuing operations was not less than US$24 million (for the six-month period ended June 30, 2025: net operating loss of US$413 million); however, due to financial costs of approximately US$43 million during the period, as well as exchange rate fluctuations, fair value revaluation of convertible loans, and one-time losses due to certain asset impairment and transaction transactions, the Group is expected to have a net loss of no more than 50 million US dollars during the period up to June 30, 2025 (6 as of June 30, 2025) (Monthly period: Net loss of US$49 million from continuing operations).

As of the date of this announcement, the Company has been exempted from financial restrictions applicable to the period under the convertible loan related agreement for the expected net loss during the period. In the future, the Group will continue to adhere to the “focus on the core” strategy, seek win-win strategic solutions for the Group's non-core/loss-making business, and properly arrange and continuously optimize the Group's debt conditions and structure to further improve the Group's operating conditions and financial performance.